AAPG

Ascentage Pharma Group International (AAPG)

About Ascentage Pharma Group International (AAPG)

Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.

Details

Daily high
$22.33
Daily low
$22.32
Price at open
$22.32
52 Week High
$48.45
52 Week Low
$17.56
Market cap
2.1B
Dividend yield
0.00%
Volume
34
Avg. volume
3,500
P/E ratio
-11.09

Ascentage Pharma Group International News

Details

Daily high
$22.33
Daily low
$22.32
Price at open
$22.32
52 Week High
$48.45
52 Week Low
$17.56
Market cap
2.1B
Dividend yield
0.00%
Volume
34
Avg. volume
3,500
P/E ratio
-11.09